News & Announcements

We’re delighted to welcome Dr Maike Stentenbach to Biotome as a Postdoctoral Scientist, joining the team in January 2026.

Biotome has just completed its first feasibility study for a peptide-based lateral flow device targeting CagA-positive H. pylori—and the results exceeded expectations.

Perth biotech awarded prestigious Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund grant to develop a first-trimester blood test that could prevent hundreds of preeclampsia cases annually in Western Australia and thousands worldwide.

This study employed peptide microarray technology (Carmona 2015) to identify highly specific linear B-cell epitopes of the SARS-CoV-2 Spike protein that can distinguish between SARS-CoV-2 infection and pre-existing immunity to seasonal coronaviruses.